New Hoque and Sons Recall (October 2025): Dry Ghoinnya Fish

On October 28, 2025, New Hoque and Sons, Inc. began a Class I recall. Reason: Un-eviscerated fish may be contaminated with Clostridia botulinum.

In plain words

What

Dry Ghoinnya Fish

Why

Un-eviscerated fish may be contaminated with Clostridia botulinum.

Where

New Jersey, New York.

Distribution as reported to FDA: NY, NJ

How serious

Class I: the FDA uses this class for a situation where there is a reasonable probability that eating the product will cause serious health problems or death.

Status: Ongoing. The recall is still in progress.

What to do

Compare the product name, size, UPC and lot or date codes below with what you have. The FDA Enforcement Report is the official record of this recall; for instructions on returns or refunds, follow the notice or contact New Hoque and Sons, Inc..

Official notice ↗

The recalled product1

FDA recall H-0202-2026 · Class I · Ongoing

Dry Ghoinnya Fish

Codes:
Expiration date of 5/19/25 UPC code is 908172635412.
Quantity:
5 cases (10 - 12 lbs. per case)

Recall record

Agency
U.S. Food and Drug Administration (FDA)
Recalling firm
New Hoque and Sons, Inc., Maspeth, NY
Recall started
October 28, 2025
FDA Enforcement Report
November 26, 2025
Initiated
Voluntary: Firm initiated
Recall number
H-0202-2026
FDA event ID
97895

Latest food recalls

JXK Enterprises, Inc is voluntarily recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug Viagra, which is not declared on the product label.

Nationwide · Ongoing

All food recalls

Recall details come from the U.S. Food and Drug Administration's Enforcement Reports (through openFDA) and from USDA's Food Safety and Inspection Service recalls and public health alerts, checked daily. MealSlash shows what the agency published and links every recall to its official notice; the notice is the authority. openFDA's note: do not rely on openFDA to make decisions regarding medical care.